Tarsus to Participate in Upcoming Investor Conference

Rhea-AI Summary

Tarsus Pharmaceuticals (NASDAQ: TARS) has announced its upcoming participation in the Barclays 27th Annual Global Healthcare Conference. The company's management will engage in a fireside chat scheduled for Tuesday, March 11th at 8:00 a.m. / 11:00 a.m. ET.

Interested parties can access a live webcast of the presentation through the events section of the Tarsus website. A replay of the session will be made available within 48 hours and will remain accessible for a time on the company's website.

News Market Reaction – TARS

+6.66%

+6.66% Session move

In the trading session that priced this news, TARS gained 6.66%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

IRVINE, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the Barclays 27^th Annual Global Healthcare Conference on Tuesday, March 11^th, at 8:00 a.m. / 11:00 a.m. ET.

A live webcast and additional information can be accessed on the events section of the Tarsus website. The replay will be available on the Tarsus website within 48 hours and will be archived for a limited time.

About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY^® (lotilaner ophthalmic solution, 0.25%) is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease.

Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com

Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com

FAQ

When is Tarsus Pharmaceuticals (TARS) presenting at the Barclays Healthcare Conference 2025?

Tarsus Pharmaceuticals will present on Tuesday, March 11th, 2025, at 8:00 a.m. PT / 11:00 a.m. ET.

How can investors watch Tarsus (TARS) presentation at the Barclays Conference?

Investors can watch the live webcast through the events section of the Tarsus website.

How long will the TARS Barclays Conference presentation replay be available?

The replay will be available on the Tarsus website within 48 hours and will be archived for a time.

What type of presentation will TARS deliver at the Barclays Healthcare Conference?

Tarsus management will participate in a fireside chat format presentation.